Healthcare provider profile · identity verified

Ryan Joseph Wenzel, MD

Family Practice · SAPULPA, OK · NPI 1750871141

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	471	135
Lisinopril	Lisinopril	411	113
Amlodipine Besylate	Amlodipine Besylate	353	119
Levothyroxine Sodium	Levothyroxine Sodium	298	87
Omeprazole	Omeprazole	290	74
Gabapentin	Gabapentin	247	76
Furosemide	Furosemide	173	61
Albuterol Sulfate Hfa	Albuterol Sulfate	165	62
Metformin Hcl	Metformin Hcl	164	49
Rosuvastatin Calcium	Rosuvastatin Calcium	160	46
Losartan Potassium	Losartan Potassium	151	59
Metoprolol Tartrate	Metoprolol Tartrate	149	48
Allopurinol	Allopurinol	142	47
Tramadol Hcl	Tramadol Hcl	140	38
Tamsulosin Hcl	Tamsulosin Hcl	138	50
Hydrochlorothiazide	Hydrochlorothiazide	132	38
Metoprolol Succinate	Metoprolol Succinate	125	39
Pantoprazole Sodium	Pantoprazole Sodium	124	40
Potassium Chloride	Potassium Chloride	121	40
Pioglitazone Hcl	Pioglitazone Hcl	113	40
Eliquis	Apixaban	110	31
Meloxicam	Meloxicam	110	49
Carvedilol	Carvedilol	108	25
Celecoxib	Celecoxib	99	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	suppressed
Duloxetine Hcl	Duloxetine Hcl	83	17
Doxycycline Hyclate	Doxycycline Hyclate	80	64
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	24
Clopidogrel	Clopidogrel Bisulfate	73	21
Hydralazine Hcl	Hydralazine Hcl	71	21
Pravastatin Sodium	Pravastatin Sodium	71	24
Escitalopram Oxalate	Escitalopram Oxalate	69	17
Simvastatin	Simvastatin	68	17
Tizanidine Hcl	Tizanidine Hcl	66	43
Lovastatin	Lovastatin	63	16
Trazodone Hcl	Trazodone Hcl	61	18
Fluticasone Propionate	Fluticasone Propionate	57	28
Ozempic	Semaglutide	57	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	18
Fluoxetine Hcl	Fluoxetine Hcl	52	11
Metformin Hcl Er	Metformin Hcl	52	17
Spironolactone	Spironolactone	52	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	16
Incruse Ellipta	Umeclidinium Bromide	48	12
Jardiance	Empagliflozin	48	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	46	35
Chlorthalidone	Chlorthalidone	44	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	11
Bupropion Hcl Sr	Bupropion Hcl	43	suppressed
Mirtazapine	Mirtazapine	43	16
Prednisone	Prednisone	42	35
Doxazosin Mesylate	Doxazosin Mesylate	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Warfarin Sodium	Warfarin Sodium	39	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	35
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	12
Trulicity	Dulaglutide	36	suppressed
Baclofen	Baclofen	35	13
Ondansetron Hcl	Ondansetron Hcl	35	17
Alendronate Sodium	Alendronate Sodium	34	14
Finasteride	Finasteride	33	14
Olmesartan Medoxomil	Olmesartan Medoxomil	33	14
Paroxetine Hcl	Paroxetine Hcl	33	11
Enalapril Maleate	Enalapril Maleate	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Acyclovir	Acyclovir	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Glipizide	Glipizide	24	suppressed
Carbamazepine	Carbamazepine	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Glimepiride	Glimepiride	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Famotidine	Famotidine	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Cefdinir	Cefdinir	19	16
Clonidine Hcl	Clonidine Hcl	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Estradiol	Estradiol	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Levofloxacin	Levofloxacin	15	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Primidone	Primidone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error